2005Zhōnghuá yàoxué zázhìRequires access

Study on bioavailability of complex chlorzoxazone dispersible tablet in healthy volunteers

Xhao Li-mei

Open publisher page 0 citations

Abstract

OBJECTIVE To compare the pharinacokinetics and relative bioavailability of complex chlorzoxazone tablet. METHODS In randomized crossover design,asingle dose complex chlorzoxazone tablet was given to 18 healthy male volunteers. The plasma concentrations of chlorzoxazone and paracetamol were determined by HPLC method. RESULTS The pharmacokinetie parameters of the two products were included: c max were(19.7±5 9 )and( 19.4 ± 5.9)μg·mL-1;t1/2were( 1.3 ± 0.5)and( 1.1 ±0.2)h;AUC were(50.6± 18.3)and(52.8± 19 8) μg·h·mL 1 , respectively. The mean relative bioavailability of the two tablets was(96.6 ± 8.8)% .CONCLUSION The results suggested that these two products were ralative bioavailability.

About this research paper

What this paper is about

OBJECTIVE To compare the pharinacokinetics and relative bioavailability of complex chlorzoxazone tablet. METHODS In randomized crossover design,asingle dose complex chlorzoxazone tablet was given to 18 healthy male volunteers. The plasma concentrations of chlorzoxazone and paracetamol were determined by HPLC method. RESULTS The pharmacokinetie parameters of the two products were included: c max were(19.7±5 9 )and( 19.4 ± 5.9)μg·mL-1;t1/2were( 1.3 ± 0.5)and( 1.1 ±0.2)h;AUC were(50.6± 18.3)and(52.8± 19 8) μg·h·mL 1 , respectively. The mean relative bioavailability of the two tablets was(96.6 ± 8.8)% .CONCLUSION The results suggested that these two products were ralative bioavailability.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To compare the pharinacokinetics and relative bioavailability of complex chlorzoxazone tablet. METHODS In randomized crossover design,asingle dose complex chlorzoxazone tablet was given to 18 healthy male volunteers. The plasma concentrations of chlorzoxazone and paracetamol were determined by HPLC method. RESULTS The pharmacokinetie parameters of the two products were included: c max were(19.7±5 9 )and( 19.4 ± 5.9)μg·mL-1;t1/2were( 1.3 ± 0.5)and( 1.1 ±0.2)h;AUC were(50.6± 18.3)and(52.8± 19 8) μg·h·mL 1 , respectively. The mean relative bioavailability of the two tablets was(96.6 ± 8.8)% .CONCLUSION The results suggested that these two products were ralative bioavailability.

Key concepts: Chlorzoxazone, Bioavailability, Crossover study, Chemistry, Bioequivalence, Pharmacology, Plasma concentration, Chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on bioavailability of complex chlorzoxazone dispersible tablet in healthy volunteers — Research Paper | ScholarLens